U.S. IVF Services Market by Cycle Type (Fresh Cycle (non-donor), Thawed IVF Cycle (non-donor), and Donor Egg IVF Cycle), and by End user (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022
The U.S. IVF services market was valued at $2,213.1million in 2015 and is estimated to reach $4,472.2 million by 2022. In-vitro fertilization (IVF) is a type of assisted reproductive technology that is used to treat fertility or genetic problems and aids in the conception of child. It is mainly carried out in clinical laboratory, where the ovum is artificially fertilized and then embryo is implanted into the uterus.
Increase in trend of middle age pregnancies, increase rate of infertility due age factor, and modern lifestyle leading to decline of fertility rates drives the market growth. The other factors that propel the growth of the IVF services market include rise in popularity of IVF service to achieve parenthood and availability of skilled IVF practitioners. High cost involved in this procedure, where average cost of this procedure is approximately $12,400 limit the market. In addition, restriction of three-parent IVF treatments in the U.S. also hinders the market growth. The development of low cost efficient novel technologies in IVF treatment are expected to provide numerous opportunities for market growth during the forecast period.
The U.S. IVF services market is segmented into cycle type and end user. By cycle type, the market is segmented as fresh cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, the market is categorized into fertility clinics, hospitals, surgical centers, and clinical research institutes.
The prominent companies, hospitals, surgical centers, fertility centers and clinical research institutes profiled in this report include.
KEY BENEFITS FOR STAKEHOLDERS
By Cycle Type
Increase in trend of middle age pregnancies, increase rate of infertility due age factor, and modern lifestyle leading to decline of fertility rates drives the market growth. The other factors that propel the growth of the IVF services market include rise in popularity of IVF service to achieve parenthood and availability of skilled IVF practitioners. High cost involved in this procedure, where average cost of this procedure is approximately $12,400 limit the market. In addition, restriction of three-parent IVF treatments in the U.S. also hinders the market growth. The development of low cost efficient novel technologies in IVF treatment are expected to provide numerous opportunities for market growth during the forecast period.
The U.S. IVF services market is segmented into cycle type and end user. By cycle type, the market is segmented as fresh cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, the market is categorized into fertility clinics, hospitals, surgical centers, and clinical research institutes.
The prominent companies, hospitals, surgical centers, fertility centers and clinical research institutes profiled in this report include.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the U.S. IVF services market
- In-depth analysis by quantitative analysis of the current market trends and estimations for 2014-2022
- The IVF services market is analyzed based on cycle type and end user
- Extensive analysis of the market is conducted by monitoring the top competitors within the market framework
By Cycle Type
- Fresh IVF Cycles (Non-Donor)
- Thawed IVF Cycles (Non-Donor)
- Donor Egg IVF Cycles
- Fertility Clinics
- Hospitals
- Surgical Centers
- Clinical Research Institutes
- Fertility and Gynecology Center Monterey Bay IVF
- Conceptions Reproductive Associates
- Servy Massey Fertility Institute
- Sher Institute for Reproductive Medicine (SIRM)
- Cardone Reproductive Medicine & Infertility
- Fertility Center of San Antonio
- Houston Fertility Center
- New hope fertility center
- Reproductive Medicine Associates of New Jersey
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDING OF THE STUDY
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. OVERVIEW
3.3. MARKET SIZE AND FORECAST
3.3.1. Number of infertility clinics, 2015
3.4. REGULATORY ISSUES, LEGISLATIONS, AND AUTHORITIES
3.5. INSURANCE REIMBURSEMENT SCENARIO
3.6. KEY IMPACTING FACTORS
3.6.1. Drivers
3.6.1.1. Increasing popularity of IVF in the U.S.
3.6.1.2. Increased rate of infertility and practices of embryo banking cycles
3.6.1.3. Delayed pregnancy
3.6.1.4. Technological advancements in IVF treatment
3.6.2. Restraints
3.6.2.1. High cost of IVF treatments in the U.S.
3.6.2.2. Restrictions on three-parent IVF treatments
3.6.2.3. Scattered Reimbursements
CHAPTER 4 U.S. IVF SERVICES MARKET, BY END USER
4.1. OVERVIEW
4.2. MARKET SIZE AND FORECAST
4.3. FERTILITY CLINICS
4.4. HOSPITALS
4.5. SURGICAL CENTERS
4.6. CLINICAL RESEARCH INSTITUTES
CHAPTER 5 U.S. IVF SERVICES MARKET, BY CYCLE TYPE
5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. FRESH IVF CYCLES (NON-DONOR)
5.4. THAWED IVF CYCLES (NON-DONOR)
5.5. DONOR EGG IVF CYCLES
CHAPTER 6 COMPANY/HOSPITALS/CLINICS PROFILES
6.1. FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF
6.1.1. Overview
6.2. CONCEPTIONS REPRODUCTIVE ASSOCIATES
6.2.1. Overview
6.3 SERVY MASSEY FERTILITY INSTITUTE
6.2.2. Overview
6.4 SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
6.2.3. Overview
6.5 CARDONE REPRODUCTIVE MEDICINE & INFERTILITY
6.2.4. Overview
6.6 FERTILITY CENTER OF SAN ANTONIO
6.2.5. Overview
6.7. HOUSTON FERTILITY CENTER
6.7.1. Overview
6.8. NEW HOPE FERTILITY CENTER
6.8.1. Overview
6.9. REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY
6.9.1. Overview
1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDING OF THE STUDY
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. OVERVIEW
3.3. MARKET SIZE AND FORECAST
3.3.1. Number of infertility clinics, 2015
3.4. REGULATORY ISSUES, LEGISLATIONS, AND AUTHORITIES
3.5. INSURANCE REIMBURSEMENT SCENARIO
3.6. KEY IMPACTING FACTORS
3.6.1. Drivers
3.6.1.1. Increasing popularity of IVF in the U.S.
3.6.1.2. Increased rate of infertility and practices of embryo banking cycles
3.6.1.3. Delayed pregnancy
3.6.1.4. Technological advancements in IVF treatment
3.6.2. Restraints
3.6.2.1. High cost of IVF treatments in the U.S.
3.6.2.2. Restrictions on three-parent IVF treatments
3.6.2.3. Scattered Reimbursements
CHAPTER 4 U.S. IVF SERVICES MARKET, BY END USER
4.1. OVERVIEW
4.2. MARKET SIZE AND FORECAST
4.3. FERTILITY CLINICS
4.4. HOSPITALS
4.5. SURGICAL CENTERS
4.6. CLINICAL RESEARCH INSTITUTES
CHAPTER 5 U.S. IVF SERVICES MARKET, BY CYCLE TYPE
5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. FRESH IVF CYCLES (NON-DONOR)
5.4. THAWED IVF CYCLES (NON-DONOR)
5.5. DONOR EGG IVF CYCLES
CHAPTER 6 COMPANY/HOSPITALS/CLINICS PROFILES
6.1. FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF
6.1.1. Overview
6.2. CONCEPTIONS REPRODUCTIVE ASSOCIATES
6.2.1. Overview
6.3 SERVY MASSEY FERTILITY INSTITUTE
6.2.2. Overview
6.4 SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
6.2.3. Overview
6.5 CARDONE REPRODUCTIVE MEDICINE & INFERTILITY
6.2.4. Overview
6.6 FERTILITY CENTER OF SAN ANTONIO
6.2.5. Overview
6.7. HOUSTON FERTILITY CENTER
6.7.1. Overview
6.8. NEW HOPE FERTILITY CENTER
6.8.1. Overview
6.9. REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY
6.9.1. Overview
LIST OF TABLES
TABLE 1. TABLE 10. U.S. IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 2. NUMBER OF FERTILITY CLINICS IN U.S. (2015)
TABLE 3. FRESH IVF CYCLE PREGNANCY RATES
TABLE 4. U.S. IVF SERVICES MARKET, BY END USER, 2014-2022 (THOUSAND)
TABLE 5. U.S. IVF SERVICES MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 6. U.S.IVF SERVICE MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 7. U.S. IVF SERVICE MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 8. FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
TABLE 9. CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
TABLE 10. SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 11. SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 12. CARDONE REPRODUCTIVE MEDICINE & INFERTILITY: BUSINESS OVERVIEW
TABLE 13. FERTILITY CENTER OF SAN ANTONIO: BUSINESS OVERVIEW
TABLE 14. HOUSTON FERTILITY CENTER: BUSINESS OVERVIEW
TABLE 15. NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
TABLE 16. REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY BUSINESS OVERVIEW
TABLE 1. TABLE 10. U.S. IVF MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND AND $MILLION)
TABLE 2. NUMBER OF FERTILITY CLINICS IN U.S. (2015)
TABLE 3. FRESH IVF CYCLE PREGNANCY RATES
TABLE 4. U.S. IVF SERVICES MARKET, BY END USER, 2014-2022 (THOUSAND)
TABLE 5. U.S. IVF SERVICES MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 6. U.S.IVF SERVICE MARKET, BY CYCLE TYPE, 2014-2022 (THOUSAND)
TABLE 7. U.S. IVF SERVICE MARKET, BY CYCLE TYPE, 2014-2022 ($MILLION)
TABLE 8. FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
TABLE 9. CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
TABLE 10. SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 11. SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 12. CARDONE REPRODUCTIVE MEDICINE & INFERTILITY: BUSINESS OVERVIEW
TABLE 13. FERTILITY CENTER OF SAN ANTONIO: BUSINESS OVERVIEW
TABLE 14. HOUSTON FERTILITY CENTER: BUSINESS OVERVIEW
TABLE 15. NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
TABLE 16. REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY BUSINESS OVERVIEW
LIST OF FIGURES
FIGURE 1. ART REGULATORY SCENARIO, U.S.
FIGURE 2. U.S. FERTILITY CLINICS IVF SERVICES MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 3. U.S. HOSPITALS IVF SERVICES MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 4. U.S. SURGICAL CENTERS IVF SERVICES MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 5. U.S. CLINICAL RESEARCH INSTITUTES IVF SERVICES MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 6. U.S. FRESH IVF CYCLE MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 7. U.S. THAWED IVF CYCLE MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 8. U.S. DONOR EGG IVF CYCLE MARKET, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
FIGURE 1. ART REGULATORY SCENARIO, U.S.
FIGURE 2. U.S. FERTILITY CLINICS IVF SERVICES MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 3. U.S. HOSPITALS IVF SERVICES MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 4. U.S. SURGICAL CENTERS IVF SERVICES MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 5. U.S. CLINICAL RESEARCH INSTITUTES IVF SERVICES MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 6. U.S. FRESH IVF CYCLE MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 7. U.S. THAWED IVF CYCLE MARKET, VOLUME AND VALUE, 2014-2022 (THOUSAND, $MILLION)
FIGURE 8. U.S. DONOR EGG IVF CYCLE MARKET, VOLUME AND VALUE, 2014-2022, (THOUSAND, $MILLION)
